The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

To evaluate the efficacy and safety of gandouling tablet in the treatment of clinical symptoms of Wilson's diasease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Maximum Age: 65
Healthy Volunteers: f
View:

• Comply with the diagnosis of Wilson's disease Guidelines for Diagnosis and Treatment of Wilson's disease 2021

• The diagnosis of TCM syndromes complies with the syndrome of phlegm and blood stasis; Other copper-removing drugs

• Patients who have been treated with complexing agents for copper-removing treatment can enter the study after a 2-week washout period

• Age ≥15 years

• Informed consent of patients or legal representatives, And sign the informed consent form.

Locations
Other Locations
China
Jun Li
RECRUITING
Hefei
Contact Information
Primary
Jun Li, Doctor
18788899919@163.com
18788899919
Time Frame
Start Date: 2023-01-01
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 240
Treatments
Experimental: Treatment group
Gandouling
Placebo_comparator: Control group
Zinc gluconate
Sponsors
Leads: Jun Li

This content was sourced from clinicaltrials.gov